HCSGHealthcare Services Group, Inc.

$25.29+54% 1Y

$25.29

$16.3552 weeks$25.32

Is the price fair?

Good

Undemanding: modest expectations priced in and cheap against its own history.

2 good, 1 without data

What the price assumes~−2% a yearderived · Jun 30, 2026

Priced for a decline (~−2% a year). The price demands less than its three-year revenue growth of 4% a year, expectations look modest.

Vs its own P/E rangecheapest in 41 quartersderived

Cheap vs its own history: P/E 14.8 vs a 25.4 median over 41 quarters (−42% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)better than 73% of the market

FCF yieldbetter than 80% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

Healthcare Services Group, Inc. trades at 14.8× earnings against 20.2× for the median Medical Care Facilities name, cheaper than its own group.

14.8

Trailing P/E · Medical Care Facilities median 20.2 · cheaper than the typical name in its group

Price / sales: 0.92
Price / sales · as of 2026-Q2
Free cash flow yield: 8.6%
Free cash flow yield · Medical Care Facilities median 6.0%
Growth the price implies: −1.5%
Growth the price implies · The price pays for −1.5% free cash flow growth a year for a decade; revenue has grown 3.6% a year over the last three.

Details›

What the market has paid for these earnings: 41 quarters of its own multiple × $1.71 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$36.03
Its own P/E history, median	$43.50
Its own P/E history, upper quartile	$60.83
52-week range	$16.35 – $25.32
Today	$25.29

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.